Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 15 May 2008

Cressey Tim R, Green Hannah, Khoo Saye, Treluyer Jean-Marc, Compagnucci Alexandra, Saidi Yacine, Lallemant Marc, Gibb Diana M, Burger David M

Abstract excerpt

BACKGROUND: The optimum strategy for stopping treatment with drugs that have different half-lives in a combination regimen to minimize the risk of selecting drug-resistant viruses remains unknown. We evaluated drug concentrations in plasma, human immunodeficiency virus (HIV) load, and development of drug resistance after a planned treatment interruption of a nonnucleoside reverse-transcriptase inhibitor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkynes
Share to Benzoxazines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-CD8 Ratio

Share to CD4 Lymphocyte Count

Share to Cyclopropanes

Share to Nevirapine

Share to Plasma

Share to Reverse Transcriptase Inhibitors

Source

Open in PubMed Open full text

Identifiers

PMID: 18419497
DOI: 10.1086/587657
PMCID: PMC3597130

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children.PMID 18419497Read ↗

Clinical implications of stopping nevirapine‐based antiretroviral therapy: relative pharmacokinetics and avoidance of drug resistanceSemantic proximity Read ↗

HIV-1 drug resistance genotypic profiles in children with undetectable plasma viremia during antiretroviral therapy.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy.Semantic proximity Read ↗

A trial of three antiretroviral regimens in HIV-1-infected children.Semantic proximity Read ↗

Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapySemantic proximity Read ↗

Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children.Semantic proximity Read ↗

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.Semantic proximity Read ↗

Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.Semantic proximity Read ↗

Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption.Semantic proximity Read ↗

Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.Semantic proximity Read ↗

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure.Semantic proximity Read ↗

Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.